JB Chem has been battered due to the currency crises in Russia. This presents an opportunity for us to tuck into this fundamentally strong Pharma company says Daljeet Kohli
Posts in category Multibagger
Stocks That Will Benefit Most From GST & Which Should Be Bought Now
ET has issued a report on the stocks that will benefit as a result of GST and which should be bought now
Aurobindo Pharma Has Immense Potential To Grow: Sharekhan
Sharekhan has issued a research report claiming that the the acquisition of Natrol is a positive development for Aurobindo Pharma and that the stock should be bought
Cash In On Gains From Gulf Oil Lubricants: Sharekhan
Sharekhan has issued a report advising investors to book part profits from the huge run up in Gulf Oil Lubricants
Sharon Bio-Medicine Price Target Slashed & Downgraded To Hold: Daljeet Kohli
Daljeet Kohli has slashed the target price of Sharon Bio-Medicine from Rs. 140 to Rs. 66. Though there is still a huge potential upside, he has downgraded the stock to ‘Hold’ to await clarity of future events
What Is Granules India & How Does It Qualify As A Potential 100-Bagger Stock?
Granules India, a low profile small-cap Pharma company, has been put on the center stage by being proclaimed as a potential 100-bagger in the Motilal Oswal Wealth Creation Study report. We need to urgently come to grips with the stock because there may be mega bucks in store for us
Strides Arcolab Is Taking Large Strides & Has Huge Upside: IIFL & Nirmal Bang
IIFL and Nirmal Bang have each issued a research report on Strides Arcolab claiming that the company has huge potential ahead
CARE Is A Strong Play On Rating Industry: ICICI Direct
ICICI Direct has issued a management meet note stating that CARE is a strong play of the rating industry
MPS Is On A Firm Footing: ICICI Direct
ICICI Direct has issued a management meet note stating that MPS has an uncomplicated business and that it is on a firm footing
Sharon Bio-Medicine Is “Under Review”: Daljeet Kohli
Sharon Bio-Medicine’s savage fall of 20% yesterday appears to have shaken Daljeet Kohli. He has issued a terse note that he is investigating the cause of the fall and that the stock is “under review” till then
Recent Comments